Skip to main content

Table 1 Number of identified programs and drug trends by province/territory (2023)a

From: Programs and practices that support pregnant people who use drugs’ access to sexual and reproductive health care in Canada: a scoping review

Province/Territory

Number of Identified Programs

Apparent opioid toxicity deaths per 100,000 (January-March 2023) [3]

Opioid-related poisoning hospitalizations per 100,000 (January-March 2023) [3]

Stimulant-related poisoning hospitalizations per 100,000 (January-March 2023) [3]

Canada

1 (Federal)

20.3

17.4

6.4

British Columbia

15

48.1

26.1

7.1

Alberta

8

38.2

25.3

7.4

Saskatchewan

2

13.1

19.1

12.1

Manitoba

2

N/A

4.8

2.6

Ontario

10

17.0

14.3

6.0

Quebec

2

5.1

N/A

N/A

New Brunswick

2

5.4

9.9

6.4

Nova Scotia

2

5.9

7.1

3.9

Prince Edward Island

0

4.7

S

S

Newfoundland and Labrador

0

6.8

12.9

4.6

Yukon

0

27.4

21.6a

S

Northwest Territories

0

0.0

21.6a

S

Nunavut

0

0.0

21.6a

S

  1. The number of unique programs identified in our review and trends in drug-related deaths and hospitalizations per 100,000 (January-March 2023) reported by province and territory
  2. N/A Data not available
  3. S Data suppressed due to low numbers in order to comply with confidentiality rules
  4. aData for all three territories combined